The stock of Ionis Pharmaceuticals Inc (NASDAQ: IONS) has decreased by -0.55 when compared to last closing price of 36.53. Despite this, the company has
The 36-month beta value for IONS is at 0.35. Analysts have varying views on the stock, with 13 analysts rating it as a “buy,” 4
Company’s 36-month beta value is 0.35.Analysts have differing opinions on the stock, with 13 analysts rating it as a “buy,” 4 as “overweight,” 7 as
Additionally, the 36-month beta value for IONS is 0.35. There are mixed opinions on the stock, with 13 analysts rating it as a “buy,” 4
The stock of Ionis Pharmaceuticals Inc (IONS) has seen a 1.41% increase in the past week, with a -9.59% drop in the past month, and
The stock of Ionis Pharmaceuticals Inc (IONS) has seen a -8.07% decrease in the past week, with a -10.21% drop in the past month, and
The 36-month beta value for IONS is at 0.37. Analysts have varying views on the stock, with 4 analysts rating it as a “buy,” 1
© 2024, Powered by Smart TechOne
